---
document_datetime: 2023-09-21 18:35:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/talmanco-epar-all-authorised-presentations_en.pdf
document_name: talmanco-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9904873
conversion_datetime: 2025-12-17 08:51:38.106758
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging       | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|---------------------------|----------------------------|
| EU/1/16/1153/001 | Talmanco          | 20 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC-alu) | 28 tablets                 |
| EU/1/16/1153/002 | Talmanco          | 20 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC-alu) | 28 x 1 tablets (unit dose) |
| EU/1/16/1153/003 | Talmanco          | 20 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC-alu) | 56 tablets                 |
| EU/1/16/1153/004 | Talmanco          | 20 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PE/PVDC-alu) | 56 x 1 tablets (unit dose) |